Oct 24, 2026
Lydian Cosmetic Surgery Clinic in Seoul details non-surgical stem cell injections for knee osteoarthritis, covering candidacy, process, costs and realistic limits on cartilage regeneration for international patients weighing treatment in Korea.
Seoul, Korea, Republic of, October 24, 2026 /NewsNetwork/ -- Lydian Cosmetic Surgery Clinic in Seoul offers non-surgical stem cell injections for knee osteoarthritis, using cells collected from a patient's own fat tissue or bone marrow. Specialists process the cells in a laboratory before injecting them into the affected knee under ultrasound guidance. The clinic presents this pathway for selected patients with mild-to-moderate disease, giving international patients a concrete option to weigh before traveling to Korea for treatment.
More information is available at https://www.lydianclinic.com/blog/knee-osteoarthritis-stem-cell-therapy-at-lydian-clinic/
Knee osteoarthritis causes pain, stiffness and reduced mobility; these symptoms can make walking, climbing stairs or standing for long periods increasingly difficult, leading many patients to search for alternatives before considering knee replacement surgery. A 2025 Cochrane review reported that stem cell injections may offer modest improvements in pain and physical function compared with placebo, describing the evidence as low-certainty with uncertain effects on structural joint changes.
At Lydian Clinic, the process begins with evaluating symptoms, imaging and medical history to determine which patients may be suitable candidates. Cells are then collected from fat tissue or bone marrow, processed and concentrated in the laboratory, and injected into the knee joint under ultrasound guidance. The clinic presents this non-surgical option as distinct from surgical procedures that implant cells directly into a cartilage defect.
Symptom improvement following injection does not establish reliable cartilage regeneration, and it does not prove that knee replacement can be avoided. Injection-based treatment remains a separate approach from surgical cell implantation, so the two should be weighed on their own terms rather than treated as interchangeable. A separate 2023 review in the Journal of Experimental Orthopaedics noted that studies use differing cell sources and preparations, which makes reported outcomes difficult to compare across treatments.
The supplied content does not list a price for Lydian Clinic's own knee stem cell treatment, and published Korean treatment estimates vary depending on cell source and processing method. Prospective patients are advised to confirm exactly what a quoted price covers, including consultation, imaging, cell collection and processing, the injection procedure, follow-up visits and rehabilitation. Clarifying these inclusions in advance helps avoid unexpected costs once treatment has begun.
Lydian Clinic positions knee stem cell injections as one non-surgical option among several for appropriately selected patients, built on thorough assessment and candid discussion of what the treatment can and cannot establish. International patients considering care in Korea are encouraged to complete a full evaluation and obtain a clear cost breakdown before committing to any plan. Working through assessment, treatment and follow-up with realistic expectations allows patients to make decisions grounded in their own circumstances rather than general marketing claims.
Contact Info:
Name: Dr. Abraham An
Email: Send Email
Organization: Lydian Cosmetic Surgery Clinic
Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam, Seoul, Seoul 06025, Korea, Republic of
Phone: +82-10-9692-5508
Website: https://www.lydianclinic.com/
Source: NewsNetwork
Release ID: 89207234
If you come across any problems, discrepancies, or concerns related to the content contained within this press release that necessitate action or if a press release requires takedown, we strongly encourage you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will be readily accessible round-the-clock to address your concerns within 8 hours and take appropriate actions to rectify identified issues or support with press release removals. Ensuring accurate and reliable information remains our unwavering commitment.
Beyond melanoma, scientists are studying cancer vaccines for glioblastoma, pancreatic cancer and more.
In Ohio, many voters say their frustration about the increase in electricity and fuel prices and the growth of data centers won’t influence whom they vote for.
President Trump’s novel deal-making is on display in upstate New York, where the administration is funneling Japanese funds into a government-owned chip factory.
A Minnesota group worried that its opposition could expose it to prosecution under the state’s deceptive-practices law. Its lawsuit could have wide implications for limiting speech around elections.
The little-known investment Martin Lewis wants you to understand
Demonstrations are expected to continue this weekend in Paris and other French cities. Some museums and tourist sites will be closed, and visitors should expect a strong police presence.
Kashim Chowdhury denied being dishonest when not telling employers he had other jobs.
Among the stakes in next month’s election is the long-running question of whether tax cuts can shape how people vote.
Pennylane, a French company, has gained market share in its home country by helping accountants work with clients. It’s aiming to expand internationally.
The Swedish automaker plans to cut another 2,500 jobs, joining competitors in offering a gloomy view of the world’s biggest car market.
AI uncovered long-hidden programming flaws, triggering a rare global cyber-security response.
The rising cost of food and alcohol drives an increase in the inflation rate, figures show.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.